Digital health tools and technologies such as artificial intelligence (AI) and machine learning (ML) are expected to further integrate into the healthcare industry due to the impact of the COVID-19 pandemic. Against the backdrop, the market for AI platforms for the entire healthcare industry is set to grow from $1.5 billion in 2019 to $4.3 billion in 2024, forecasts GlobalData, a leading data and analytics company.
Various healthcare companies are already implementing high-tech solutions into existing healthcare systems. French biotechnology company Genomic Vision, which specializes in the development and commercialization of diagnostic solutions for genetic diseases and cancers, has recently launched FiberSmart, a new technology that enables the visualization and analysis of long DNA fibers at high resolution.
Genomic Vision claims that FiberSmart has the potential to improve the accuracy and efficiency of genetic disease diagnosis and treatment, leading to better patient outcomes and reduced healthcare costs.
Kamilla Kan, Medical Analyst at GlobalData, comments: “The integration of digital health tools and technologies such as AI and ML to analyze large amounts of data and identify patterns and insights is transforming the healthcare industry and paving the way for more personalized and efficient healthcare. Furthermore, AI is being used to improve the accuracy and efficiency of diagnoses, identify new treatments and therapies, and even predict and prevent disease outbreaks.
“The growing market for AI platforms in healthcare reflects the increasing demand for innovative solutions that can improve patient outcomes and reduce costs. As companies like Genomic Vision continue to develop and implement high-tech solutions, GlobalData expects even more significant advancements in the field of healthcare in the coming years.”
